DRUGBYAI.COM
Domain Highlights
Drugbyai.com combines a high-value pharmaceutical keyword with the current artificial intelligence trend to create a specific, industry-focused brandable. This name aligns well with the growing biotech and computational pharmacology sectors, making it a logical fit for a drug discovery startup or a specialized health-tech news platform. Competitive auction activity suggests significant market interest, especially given the notable spread between the current bidding and the four-figure appraisal. The domain offers a clear development path for investors targeting the intersection of AI and life sciences.
How each scoring factor contributed to the overall rating of 71/100.
| Domain | Date Sold | Venue | Est. Price |
|---|---|---|---|
| TDOMAIN.COM | Aug 27, 2026 | GoDaddy | $250 – $500+ |
| WEIZTEN.COM | Aug 27, 2026 | Dynadot | $500 – $1,000+ |
| LCYAXIN.COM | Aug 27, 2026 | Dynadot | $500 – $1,000+ |
| CHENGLUCM.COM | Aug 27, 2026 | Dynadot | $500 – $1,000+ |
| MEITACHAIN.COM | Aug 27, 2026 | Dynadot | $500 – $1,000+ |
| XICECLOUD.COM | Aug 27, 2026 | Dynadot | $500 – $1,000+ |
Prices are estimated ranges based on last known bids, not confirmed sale prices.
Browse Archive